Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.37 |
| ▸ | DPP4 | P27487 | 1/20 | 0.35 |
| ▸ | RXRA | P19793 | 1/20 | 0.35 |
| ▸ | RXRB | P28702 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL263719 | 0.80 | ALDH1A1 (0.42) | TSHRLMNASMN1; SMN2SLC6A4SLC6A2 | |
| SCHEMBL14925378 | 0.80 | MEN1 (0.43) | TSHRLMNASMN1; SMN2HPGDL3MBTL1 | |
| SCHEMBL521826 | 0.77 | MRGPRX4 (0.40) | TSHRLMNASMN1; SMN2SLC6A4SLC6A2 | |
| SCHEMBL2723162 | 0.77 | ALDH1A1 (0.45) | LMNASLC6A4SLC6A2SLC6A3ALDH1A1 | |
| SCHEMBL7769417 | 0.75 | TSHR (0.53) | TSHRLMNASMN1; SMN2HPGDSLC6A4 | |
| SCHEMBL1436765 | 0.75 | HPGD (0.59) | TSHRLMNASMN1; SMN2HPGDSLC6A4 | |
| SCHEMBL10935253 | 0.72 | — | — | |
| SCHEMBL17224442 | 0.72 | KMT2A (0.38) | SMN1; SMN2HPGDALDH1A1KMT2A | |
| SCHEMBL4469317 | 0.72 | SLC6A4 (0.37) | SLC6A4SLC6A2SLC6A3KCNH2 | |
| SCHEMBL337001 | 0.72 | SLC6A4 (0.42) | SMN1; SMN2SLC6A4L3MBTL1SLC6A2SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 847 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119978389-A | Boron-containing oligomer for aging-resistant high-transparency addition-type silicon rubber, and preparation method and application thereof | 中国科学院化学研究所 | 2025-05-13 | — | — | CN | claimed |
| CN-109180499-B | Preparation method of rasagiline mesylate and intermediate thereof | 上海博志研新药物技术有限公司 | 2021-04-30 | — | — | CN | claimed |
| CN-110760070-B | Preparation method of functional compound RGO-IONP-PEG | 海南省妇幼保健院 | 2020-11-10 | — | — | CN | claimed |
| CN-110760070-A | Preparation method of functional compound RGO-IONP-PEG | 海南省妇幼保健院 | 2020-02-07 | — | — | CN | claimed |
| US-10014475-B2 | Graphene nanoribbons as semiconductors for organic thin film transistors | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2018-07-03 | — | — | US | claimed |
| US-20160087212-A1 | GRAPHENE NANORIBBONS AS SEMICONDUCTORS FOR ORGANIC THIN FILM TRANSISTORS | CRESTLINE DIRECT FINANCE, L.P. | 2016-03-24 | — | — | US | claimed |
| US-9233967-B2 | Process for the preparation of sitagliptin and intermediate compounds | CIPLA LIMITED (IN) | 2016-01-12 | — | — | US | claimed |
| US-20150197523-A1 | PROCESS FOR THE PREPARATION OF SITAGLIPTIN AND INTERMEDIATE COMPOUNDS | CIPLA LIMITED (IN) | 2015-07-16 | — | — | US | claimed |
| EP-2882752-A1 | PROCESS FOR THE PREPARATION OF SITAGLIPTIN AND INTERMEDIATE COMPOUNDS | Cipla Limited (IN) | 2015-06-17 | — | — | EP | claimed |
| US-8921299-B2 | Detergents having acceptable color | THE PROCTER & GAMBLE COMPANY (US) | 2014-12-30 | — | — | US | claimed |
| WO-2014171931-A1 | GRAPHENE NANORIBBONS AS SEMICONDUCTORS | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-10-23 | — | — | WO | claimed |
| WO-2014023930-A1 | PROCESS FOR THE PREPARATION OF SITAGLIPTIN AND INTERMEDIATE COMPOUNDS | CIPLA LIMITED (IN) | 2014-02-13 | — | — | WO | claimed |
| WO-1995005081-A1 | BIOCIDAL COMPOSITIONS CONTAINING ORGANOBORON COMPOUNDS | U.S. BORAX INC. (US) | 1995-02-23 | — | — | WO | claimed |
| EP-3911640-B1 | PCSK9 INHIBITORS FOR USE IN THERAPY, ESPECIALLY THE TREATMENT OF CARDIOVASCULAR DISEASE | ASTRAZENECA AB (SE) | 2026-05-13 | — | — | EP | disclosed |
| CN-122028604-A | Organic electroluminescent element and electronic device including the same | 出光兴产株式会社 | 2026-05-12 | — | — | CN | disclosed |
| US-12624032-B2 | Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases | UNIVERSITY OF HOUSTON SYSTEM (US) | 2026-05-12 | — | — | US | disclosed |
| WO-2000066571-A1 | CYCLOCARBAMATE DERIVATIVES AS PROGESTERONE RECEPTOR MODULATORS | AMERICAN HOME PRODUCTS CORPORATION (US) | 2000-11-09 | — | — | WO | disclosed |
| WO-2000066164-A1 | CONTRACEPTIVE COMPOSITIONS CONTAINING ANTIPROGESTINIC AND PROGESTINIC | AMERICAN HOME PRODUCTS CORPORATION (US) | 2000-11-09 | — | — | WO | disclosed |
| WO-2000066570-A1 | CYCLOTHIOCARBAMATE DERIVATIVES AS PROGESTERONE RECEPTOR MODULATORS | AMERICAN HOME PRODUCTS CORPORATION (US) | 2000-11-09 | — | — | WO | disclosed |
| WO-1995005081-A1 | BIOCIDAL COMPOSITIONS CONTAINING ORGANOBORON COMPOUNDS | U.S. BORAX INC. (US) | 1995-02-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10014475-B2 | Graphene nanoribbons as semiconductors for organic thin film transistors | STRA6, OR10J3, EPCAM | TSHR 1452/4885LMNA 4404/4885SMN1; SMN2 3246/4885 |
| US-20150197523-A1 | PROCESS FOR THE PREPARATION OF SITAGLIPTIN AND INTERMEDIATE COMPOUNDS | DPP4, DPP7, DPP9 | TSHR 803/4885LMNA 2767/4885SMN1; SMN2 879/4885 |
| US-12624032-B2 | Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases | RIPK2, RIPK1, RIPK4 | TSHR 1679/4885LMNA 790/4885SMN1; SMN2 936/4885 |
| US-20160087212-A1 | GRAPHENE NANORIBBONS AS SEMICONDUCTORS FOR ORGANIC THIN FILM TRANSISTORS | STRA6, OR10J3, EPCAM | TSHR 1452/4885LMNA 4404/4885SMN1; SMN2 3246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.